Mutant parasite could stop malaria in its tracks

September 21, 2012 in Diseases, Conditions, Syndromes

Mutant parasite could stop malaria in its tracks

Enlarge

(Medical Xpress)—University of Nottingham Malaria experts have found a way of disabling one of the many phosphatase proteins which breathe life into the malaria parasite. The result is a mutant which is unable to complete the complex life cycle crucial to its development. The discovery could help to design drugs to save thousands of lives.

The research led by Dr Rita Tewari in the Centre for Genetics and Genomics in the School of Biology in collaboration with the University of Oxford, Imperial College London, the University of Leicester and the MRC National Institute for Medical Research, has been published in the prestigious open access journal PLOS Pathogens.

The researchers, funded by the MRC and the Wellcome Trust, have worked out how the unique enzyme—PPKL phosphatase—controls the development of the parasite at an essential stage for transmission. By removing this enzyme other proteins fail to work properly and the resulting mutant has the wrong shape to burrow through the stomach wall of the female Anopheles mosquito and pass on the disease to humans.

Approximately 40 phosphatase enzymes are present in the genome of malaria parasite—PPKL is the first whose function is identified. The research group has already begun work on identifying the rest.

Dr Tewari said: "This is the first step in understanding the functional role of phosphatases in malaria. This enzyme is absent in humans and so it can be explored as a good target for and transmission. The control of parasite transmission is important in order to prevent the spread of malaria. Targeting PPKL can be an important player in this process."

The life of a malaria parasite

Malaria is spread by transmission by the female Anopheles mosquito. The of the malaria parasite is complex. The sporozoite form of the parasite is injected into the stream with mosquito saliva. It then takes just 30 minutes for the to find and enter . Within five to seven days they have developed into thousands of merozoites. These merozoites burst out of the liver, into the and invade red where the parasite multiplies again. Two days later new merozoites burst from the blood cells and infect more blood cells. Some merozoites develop into gametocytes—the sexual stages of the parasite—and these are taken up by another mosquito while it is taking its blood meal. Inside the mosquito gut the gametocytes develop into gametes and fuse to form a zygote. It is at this stage—when the zygote is transforming into a mobile ookinete—that the scientists can strike.

Breaking the complex life cycle

The banana shape of the ookinete gives it a special tip so it can invade the gut wall. The research group has shown that the abnormal ookinetes have lost their 'banana' shape and all their essential functions. If it can't break through the gut wall the transmission of malaria is stopped.

Tony Holder, Head of Parasitology at the MRC National Institute for Medical Research UK and a senior collaborator in the study, said: "Transmission through the mosquito represents a bottle neck in the parasite's life cycle. Intervention strategies to these stages will be essential for the long term goal to eradicate and finally eliminate ."

More information: After publication the full research paper can be found at: dx.plos.org/10.137… ppat.1002948.

Journal reference: PLoS Pathogens search and more info website

Provided by University of Nottingham search and more info website

4.5 /5 (4 votes)  

Rank 4.5 /5 (4 votes)
Relevant PhysicsForums posts

More news stories

Researchers find genetic risk factor for pulmonary fibrosis

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...

Diseases, Conditions, Syndromes created 4 hours ago | popularity not rated yet | comments 0

Biomarkers discovered for inflammatory bowel disease

Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...

Diseases, Conditions, Syndromes created 4 hours ago | popularity not rated yet | comments 0

CDC says high number of public pools contain microbes

(HealthDay)—Three-quarters of public schools in the metro Atlanta area contain microbes, including bacteria indicating the presence of fecal matter, according to research published in the May 17 issue of ...

Diseases, Conditions, Syndromes created 5 hours ago | popularity not rated yet | comments 0

Study examines outbreak of spinal infections in Michigan

(HealthDay)—Factors such as increased case finding may explain why Michigan had half of the total spinal infections associated with contaminated methylprednisolone acetate in the recent fungal meningitis ...

Diseases, Conditions, Syndromes created 5 hours ago | popularity not rated yet | comments 0

World not ready for mass flu outbreak, WHO says

The world is unprepared for a massive virus outbreak, the deputy chief of the World Health Organization warned Tuesday, amid fears that H7N9 bird flu striking China could morph into a form that spreads easily among people.

Diseases, Conditions, Syndromes created 6 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.